Compile Data Set for Download or QSAR

Found 70 hits of ec50 data for polymerid = 49000176,50001049,50001763,50002231,50004058   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Adenylate cyclase type 5 (Homo sapiens (Human))	BDBM50051588 (CHEMBL429362 | His-Ser-Gln-thr-Phe-Thr-Ser-Asp-Tyr...) Show SMILES CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)Cc1c[nH]cn1)[C@H](C)O)[C@H](C)O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O Show InChI InChI=1S/C153H225N43O49S/c1-72(2)52-97(133(226)176-96(47-51-246-11)132(225)184-104(60-115(159)209)143(236)196-123(78(10)203)151(244)245)179-137(230)103(58-83-64-167-89-29-19-18-28-87(83)89)183-131(224)95(43-46-114(158)208)177-148(241)120(74(5)6)194-141(234)101(54-79-24-14-12-15-25-79)182-138(231)105(61-117(211)212)185-130(223)94(42-45-113(157)207)171-124(217)75(7)170-127(220)91(31-22-49-165-152(160)161)172-128(221)92(32-23-50-166-153(162)163)174-146(239)110(69-199)191-140(233)107(63-119(215)216)186-134(227)98(53-73(3)4)178-135(228)99(56-81-33-37-85(204)38-34-81)180-129(222)90(30-20-21-48-154)173-145(238)109(68-198)190-136(229)100(57-82-35-39-86(205)40-36-82)181-139(232)106(62-118(213)214)187-147(240)111(70-200)192-150(243)122(77(9)202)195-142(235)102(55-80-26-16-13-17-27-80)188-149(242)121(76(8)201)193-116(210)66-168-126(219)93(41-44-112(156)206)175-144(237)108(67-197)189-125(218)88(155)59-84-65-164-71-169-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,167,197-205H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H,164,169)(H,168,219)(H,170,220)(H,171,217)(H,172,221)(H,173,238)(H,174,239)(H,175,237)(H,176,226)(H,177,241)(H,178,228)(H,179,230)(H,180,222)(H,181,232)(H,182,231)(H,183,224)(H,184,225)(H,185,223)(H,186,227)(H,187,240)(H,188,242)(H,189,218)(H,190,229)(H,191,233)(H,192,243)(H,193,210)(H,194,234)(H,195,235)(H,196,236)(H,211,212)(H,213,214)(H,215,216)(H,244,245)(H4,160,161,165)(H4,162,163,166)/t75-,76-,77-,78+,88+,90-,91-,92-,93+,94-,95-,96-,97-,98-,99-,100+,101-,102+,103-,104-,105-,106+,107-,108+,109-,110-,111+,120-,121+,122+,123-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	8	n/a	n/a	n/a	n/a
University of Arizona Curated by ChEMBL					Assay Description Ability of the Compound to activate Adenylate cyclase activity was measured by the conversion of [alpha-32P]ATP to 3'5'-cyclic AMP				J Med Chem 39: 2449-55 (1996) Article DOI: 10.1021/jm960130b BindingDB Entry DOI: 10.7270/Q2JH3MT3
					More data for this Ligand-Target Pair
Adenylate cyclase type 5 (Homo sapiens (Human))	BDBM50004822 ((R)-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine...) Show SMILES Oc1cc2CCNC[C@H](c3ccccc3)c2cc1O Show InChI InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2/t14-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Patents Similars	PubMed	n/a	n/a	n/a	n/a	80	n/a	n/a	n/a	n/a
Royal Danish School of Pharmacy Curated by ChEMBL					Assay Description Effective concentration required to stimulate Adenylate cyclase				J Med Chem 33: 2197-204 (1990) BindingDB Entry DOI: 10.7270/Q2TD9XZB
					More data for this Ligand-Target Pair
Adenylate cyclase type 5 (Homo sapiens (Human))	BDBM50010714 (1-p-Tolyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,...) Show SMILES Cc1ccc(cc1)[C@H]1CNCCc2cc(O)c(O)cc12 Show InChI InChI=1S/C17H19NO2/c1-11-2-4-12(5-3-11)15-10-18-7-6-13-8-16(19)17(20)9-14(13)15/h2-5,8-9,15,18-20H,6-7,10H2,1H3/t15-/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	n/a	n/a	210	n/a	n/a	n/a	n/a
Royal Danish School of Pharmacy Curated by ChEMBL					Assay Description Effective concentration required to stimulate Adenylate cyclase				J Med Chem 33: 2197-204 (1990) BindingDB Entry DOI: 10.7270/Q2TD9XZB
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052140 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCN2CCCCC2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C30H48N2O8/c1-8-27(5)18-21(35)30(37)28(6)20(34)12-13-26(3,4)23(28)22(24(38-19(2)33)29(30,7)40-27)39-25(36)31-14-17-32-15-10-9-11-16-32/h8,20,22-24,34,37H,1,9-18H2,2-7H3,(H,31,36)/t20-,22-,23-,24-,27-,28-,29+,30-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	500	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50010261 ((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10...) Show SMILES CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C |r| Show InChI InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	500	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052141 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-[2-...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCc2ccc(N)cc2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C31H44N2O8/c1-8-28(5)17-22(36)31(38)29(6)21(35)13-15-27(3,4)24(29)23(25(39-18(2)34)30(31,7)41-28)40-26(37)33-16-14-19-9-11-20(32)12-10-19/h8-12,21,23-25,35,38H,1,13-17,32H2,2-7H3,(H,33,37)/t21-,23-,24-,25-,28-,29-,30+,31-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	500	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052150 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCO)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C25H39NO9/c1-8-22(5)13-16(30)25(32)23(6)15(29)9-10-21(3,4)18(23)17(34-20(31)26-11-12-27)19(33-14(2)28)24(25,7)35-22/h8,15,17-19,27,29,32H,1,9-13H2,2-7H3,(H,26,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	500	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052137 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCc2ccccn2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C30H42N2O8/c1-8-27(5)17-21(35)30(37)28(6)20(34)12-14-26(3,4)23(28)22(24(38-18(2)33)29(30,7)40-27)39-25(36)32-16-13-19-11-9-10-15-31-19/h8-11,15,20,22-24,34,37H,1,12-14,16-17H2,2-7H3,(H,32,36)/t20-,22-,23-,24-,27-,28-,29+,30-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	600	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50010274 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(2-...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCN)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C25H40N2O8/c1-8-22(5)13-16(30)25(32)23(6)15(29)9-10-21(3,4)18(23)17(34-20(31)27-12-11-26)19(33-14(2)28)24(25,7)35-22/h8,15,17-19,29,32H,1,9-13,26H2,2-7H3,(H,27,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	600	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50010267 (CHEMBL92719 | [2-(4-Hydroxy-phenyl)-ethyl]-carbami...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccc(O)cc1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H41NO8/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(23(34)28(29,6)38-26)37-24(35)30-15-13-17-8-10-18(31)11-9-17/h7-11,19,21-23,31-32,34,36H,1,12-16H2,2-6H3,(H,30,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	630	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052124 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES COCCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C26H41NO9/c1-9-23(5)14-17(30)26(32)24(6)16(29)10-11-22(3,4)19(24)18(35-21(31)27-12-13-33-8)20(34-15(2)28)25(26,7)36-23/h9,16,18-20,29,32H,1,10-14H2,2-8H3,(H,27,31)/t16-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	700	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50010268 ((2-Amino-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,10...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCN)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C23H38N2O7/c1-7-20(4)12-14(27)23(30)21(5)13(26)8-9-19(2,3)16(21)15(28)17(22(23,6)32-20)31-18(29)25-11-10-24/h7,13,15-17,26,28,30H,1,8-12,24H2,2-6H3,(H,25,29)/t13-,15-,16-,17-,20-,21-,22+,23-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	700	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052117 (CHEMBL317534 | Cyclohexylmethyl-carbamic acid (3R,...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCC1CCCCC1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H45NO7/c1-7-25(4)15-19(31)28(34)26(5)18(30)13-14-24(2,3)21(26)20(22(32)27(28,6)36-25)35-23(33)29-16-17-11-9-8-10-12-17/h7,17-18,20-22,30,32,34H,1,8-16H2,2-6H3,(H,29,33)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052143 (CHEMBL93242 | [2-(4-Amino-phenyl)-ethyl]-carbamic ...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccc(N)cc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H42N2O7/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(34)23(28(29,6)38-26)37-24(35)31-15-13-17-8-10-18(30)11-9-17/h7-11,19,21-23,32,34,36H,1,12-16,30H2,2-6H3,(H,31,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.10E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052129 (CHEMBL93259 | Phenethyl-carbamic acid (3R,4aR,5S,6...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccccc1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H41NO7/c1-7-26(4)17-20(32)29(35)27(5)19(31)13-15-25(2,3)22(27)21(23(33)28(29,6)37-26)36-24(34)30-16-14-18-11-9-8-10-12-18/h7-12,19,21-23,31,33,35H,1,13-17H2,2-6H3,(H,30,34)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.10E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052130 ((2-Pyridin-2-yl-ethyl)-carbamic acid (3R,4aR,5S,6S...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccccn1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H40N2O7/c1-7-25(4)16-19(32)28(35)26(5)18(31)11-13-24(2,3)21(26)20(33)22(27(28,6)37-25)36-23(34)30-15-12-17-10-8-9-14-29-17/h7-10,14,18,20-22,31,33,35H,1,11-13,15-16H2,2-6H3,(H,30,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.10E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052126 ((2-Piperidin-1-yl-ethyl)-carbamic acid (3R,4aR,5S,...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCN1CCCCC1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H46N2O7/c1-7-25(4)17-19(32)28(35)26(5)18(31)11-12-24(2,3)21(26)20(33)22(27(28,6)37-25)36-23(34)29-13-16-30-14-9-8-10-15-30/h7,18,20-22,31,33,35H,1,8-17H2,2-6H3,(H,29,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.20E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052131 (CHEMBL93521 | Propyl-carbamic acid (3R,4aR,5S,6S,6...) Show SMILES CCCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C24H39NO7/c1-8-12-25-19(29)31-18-16(28)17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(18,24)7/h9,14,16-18,26,28,30H,2,8,10-13H2,1,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	1.30E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50010269 (CHEMBL327672 | [2-(4-Hydroxy-phenyl)-ethyl]-carbam...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccc(O)cc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H41NO8/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(34)23(28(29,6)38-26)37-24(35)30-15-13-17-8-10-18(31)11-9-17/h7-11,19,21-23,31-32,34,36H,1,12-16H2,2-6H3,(H,30,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.40E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052142 ((2-Hydroxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCO)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C23H37NO8/c1-7-20(4)12-14(27)23(30)21(5)13(26)8-9-19(2,3)16(21)15(28)17(22(23,6)32-20)31-18(29)24-10-11-25/h7,13,15-17,25-26,28,30H,1,8-12H2,2-6H3,(H,24,29)/t13-,15-,16-,17-,20-,21-,22+,23-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	1.40E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052123 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCc2ccccc2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C31H43NO8/c1-8-28(5)18-22(35)31(37)29(6)21(34)14-16-27(3,4)24(29)23(25(38-19(2)33)30(31,7)40-28)39-26(36)32-17-15-20-12-10-9-11-13-20/h8-13,21,23-25,34,37H,1,14-18H2,2-7H3,(H,32,36)/t21-,23-,24-,25-,28-,29-,30+,31-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.50E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052113 ((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES COCCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(28)18(23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052148 ((2-Piperidin-1-yl-ethyl)-carbamic acid (3R,4aR,5S,...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCN1CCCCC1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H46N2O7/c1-7-25(4)17-19(32)28(35)26(5)18(31)11-12-24(2,3)21(26)20(22(33)27(28,6)37-25)36-23(34)29-13-16-30-14-9-8-10-15-30/h7,18,20-22,31,33,35H,1,8-17H2,2-6H3,(H,29,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.70E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052146 ((2-Pyridin-2-yl-ethyl)-carbamic acid (3R,4aR,5S,6S...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccccn1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H40N2O7/c1-7-25(4)16-19(32)28(35)26(5)18(31)11-13-24(2,3)21(26)20(22(33)27(28,6)37-25)36-23(34)30-15-12-17-10-8-9-14-29-17/h7-10,14,18,20-22,31,33,35H,1,11-13,15-16H2,2-6H3,(H,30,34)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	1.80E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052125 (3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5,10,10b-Trihy...) Show SMILES CCOC(=O)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C26H41NO9/c1-8-23(5)14-16(29)26(33)24(6)15(28)10-12-22(3,4)19(24)18(20(31)25(26,7)36-23)35-21(32)27-13-11-17(30)34-9-2/h8,15,18-20,28,31,33H,1,9-14H2,2-7H3,(H,27,32)/t15-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052127 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CCCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C26H41NO8/c1-9-13-27-21(31)34-18-19-22(4,5)12-11-16(29)24(19,7)26(32)17(30)14-23(6,10-2)35-25(26,8)20(18)33-15(3)28/h10,16,18-20,29,32H,2,9,11-14H2,1,3-8H3,(H,27,31)/t16-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052144 ((2-Hydroxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCO)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C23H37NO8/c1-7-20(4)12-14(27)23(30)21(5)13(26)8-9-19(2,3)16(21)15(17(28)22(23,6)32-20)31-18(29)24-10-11-25/h7,13,15-17,25-26,28,30H,1,8-12H2,2-6H3,(H,24,29)/t13-,15-,16-,17-,20-,21-,22+,23-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052134 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(3,...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCCC(C)(C)C)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C29H47NO8/c1-11-26(8)16-19(33)29(35)27(9)18(32)12-13-25(6,7)21(27)20(22(36-17(2)31)28(29,10)38-26)37-23(34)30-15-14-24(3,4)5/h11,18,20-22,32,35H,1,12-16H2,2-10H3,(H,30,34)/t18-,20-,21-,22-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052132 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-(2-...) Show SMILES CN(C)CCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C27H44N2O8/c1-10-24(5)15-18(32)27(34)25(6)17(31)11-12-23(3,4)20(25)19(36-22(33)28-13-14-29(8)9)21(35-16(2)30)26(27,7)37-24/h10,17,19-21,31,34H,1,11-15H2,2-9H3,(H,28,33)/t17-,19-,20-,21-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052111 ((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES COCCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(18(28)23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052113 ((2-Methoxy-ethyl)-carbamic acid (3R,4aR,5S,6S,6aS,...) Show SMILES COCCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C24H39NO8/c1-8-21(4)13-15(27)24(30)22(5)14(26)9-10-20(2,3)17(22)16(28)18(23(24,6)33-21)32-19(29)25-11-12-31-7/h8,14,16-18,26,28,30H,1,9-13H2,2-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052112 ((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...) Show SMILES CC(C)(C)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(31)20(26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052136 (3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-Acetoxy-10,1...) Show SMILES CCOC(=O)CCNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C28H43NO10/c1-9-25(6)15-18(32)28(35)26(7)17(31)11-13-24(4,5)21(26)20(22(37-16(3)30)27(28,8)39-25)38-23(34)29-14-12-19(33)36-10-2/h9,17,20-22,31,35H,1,10-15H2,2-8H3,(H,29,34)/t17-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052120 (CHEMBL419139 | Isobutyl-carbamic acid (3R,4aR,5S,6...) Show SMILES CC(C)CNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C25H41NO7/c1-9-22(6)12-16(28)25(31)23(7)15(27)10-11-21(4,5)18(23)17(19(29)24(25,8)33-22)32-20(30)26-13-14(2)3/h9,14-15,17-19,27,29,31H,1,10-13H2,2-8H3,(H,26,30)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052115 ((2-Dimethylamino-ethyl)-carbamic acid (3R,4aR,5S,6...) Show SMILES CN(C)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C25H42N2O7/c1-9-22(4)14-16(29)25(32)23(5)15(28)10-11-21(2,3)18(23)17(30)19(24(25,6)34-22)33-20(31)26-12-13-27(7)8/h9,15,17-19,28,30,32H,1,10-14H2,2-8H3,(H,26,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052139 (Allyl-carbamic acid (3R,4aR,5S,6S,6aS,10S,10aR,10b...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCC=C)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C24H37NO7/c1-8-12-25-19(29)31-16-17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(24,7)18(16)28/h8-9,14,16-18,26,28,30H,1-2,10-13H2,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052118 (CHEMBL330704 | Propyl-carbamic acid (3R,4aR,5S,6S,...) Show SMILES CCCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C24H39NO7/c1-8-12-25-19(29)31-16-17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(24,7)18(16)28/h9,14,16-18,26,28,30H,2,8,10-13H2,1,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052119 ((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...) Show SMILES CC(C)(C)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(20(31)26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052116 (CHEMBL93260 | Isobutyl-carbamic acid (3R,4aR,5S,6S...) Show SMILES CC(C)CNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C25H41NO7/c1-9-22(6)12-16(28)25(31)23(7)15(27)10-11-21(4,5)18(23)17(29)19(24(25,8)33-22)32-20(30)26-13-14(2)3/h9,14-15,17-19,27,29,31H,1,10-13H2,2-8H3,(H,26,30)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052128 (CHEMBL92687 | Cyclohexylmethyl-carbamic acid (3R,4...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCC1CCCCC1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C28H45NO7/c1-7-25(4)15-19(31)28(34)26(5)18(30)13-14-24(2,3)21(26)20(32)22(27(28,6)36-25)35-23(33)29-16-17-11-9-8-10-12-17/h7,17-18,20-22,30,32,34H,1,8-16H2,2-6H3,(H,29,33)/t18-,20-,21-,22-,25-,26-,27+,28-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052122 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10...) Show SMILES CC(C)CNC(=O)O[C@@H]1[C@H](OC(C)=O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C27H43NO8/c1-10-24(7)13-18(31)27(33)25(8)17(30)11-12-23(5,6)20(25)19(35-22(32)28-14-15(2)3)21(34-16(4)29)26(27,9)36-24/h10,15,17,19-21,30,33H,1,11-14H2,2-9H3,(H,28,32)/t17-,19-,20-,21-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052121 (3-((3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-Trihy...) Show SMILES CCOC(=O)CCNC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C26H41NO9/c1-8-23(5)14-16(29)26(33)24(6)15(28)10-12-22(3,4)19(24)18(31)20(25(26,7)36-23)35-21(32)27-13-11-17(30)34-9-2/h8,15,18-20,28,31,33H,1,9-14H2,2-7H3,(H,27,32)/t15-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052145 (CHEMBL93252 | [2-(4-Amino-phenyl)-ethyl]-carbamic ...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](OC(=O)NCCc1ccc(N)cc1)[C@H](O)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H42N2O7/c1-7-26(4)16-20(33)29(36)27(5)19(32)12-14-25(2,3)22(27)21(23(34)28(29,6)38-26)37-24(35)31-15-13-17-8-10-18(30)11-9-17/h7-11,19,21-23,32,34,36H,1,12-16,30H2,2-6H3,(H,31,35)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052133 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-cyc...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCC2CCCCC2)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C30H47NO8/c1-8-27(5)16-21(34)30(36)28(6)20(33)14-15-26(3,4)23(28)22(24(37-18(2)32)29(30,7)39-27)38-25(35)31-17-19-12-10-9-11-13-19/h8,19-20,22-24,33,36H,1,9-17H2,2-7H3,(H,31,35)/t20-,22-,23-,24-,27-,28-,29+,30-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052149 (Acetic acid (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6-all...) Show SMILES CC(=O)O[C@H]1[C@@H](OC(=O)NCC=C)[C@H]2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]2(O)C(=O)C[C@@](C)(O[C@]12C)C=C Show InChI InChI=1S/C26H39NO8/c1-9-13-27-21(31)34-18-19-22(4,5)12-11-16(29)24(19,7)26(32)17(30)14-23(6,10-2)35-25(26,8)20(18)33-15(3)28/h9-10,16,18-20,29,32H,1-2,11-14H2,3-8H3,(H,27,31)/t16-,18-,19-,20-,23-,24-,25+,26-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052138 (Allyl-carbamic acid (3R,4aR,5S,6S,6aS,10S,10aR,10b...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCC=C)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C24H37NO7/c1-8-12-25-19(29)31-18-16(28)17-20(3,4)11-10-14(26)22(17,6)24(30)15(27)13-21(5,9-2)32-23(18,24)7/h8-9,14,16-18,26,28,30H,1-2,10-13H2,3-7H3,(H,25,29)/t14-,16-,17-,18-,21-,22-,23+,24-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052114 (CHEMBL93468 | Phenethyl-carbamic acid (3R,4aR,5S,6...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccccc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H41NO7/c1-7-26(4)17-20(32)29(35)27(5)19(31)13-15-25(2,3)22(27)21(33)23(28(29,6)37-26)36-24(34)30-16-14-18-11-9-8-10-12-18/h7-12,19,21-23,31,33,35H,1,13-17H2,2-6H3,(H,30,34)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052135 ((2-Dimethylamino-ethyl)-carbamic acid (3R,4aR,5S,6...) Show SMILES CN(C)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C25H42N2O7/c1-9-22(4)14-16(29)25(32)23(5)15(28)10-11-21(2,3)18(23)17(19(30)24(25,6)34-22)33-20(31)26-12-13-27(7)8/h9,15,17-19,28,30,32H,1,10-14H2,2-8H3,(H,26,31)/t15-,17-,18-,19-,22-,23-,24+,25-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	>2.00E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Ability to activate the conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052114 (CHEMBL93468 | Phenethyl-carbamic acid (3R,4aR,5S,6...) Show SMILES CC1(C)CC[C@H](O)[C@@]2(C)[C@H]1[C@H](O)[C@H](OC(=O)NCCc1ccccc1)[C@@]1(C)O[C@](C)(CC(=O)[C@]21O)C=C Show InChI InChI=1S/C29H41NO7/c1-7-26(4)17-20(32)29(35)27(5)19(31)13-15-25(2,3)22(27)21(33)23(28(29,6)37-26)36-24(34)30-16-14-18-11-9-8-10-12-18/h7-12,19,21-23,31,33,35H,1,13-17H2,2-6H3,(H,30,34)/t19-,21-,22-,23-,26-,27-,28+,29-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	2.10E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair
Adenylate cyclase type 1 (Homo sapiens (Human))	BDBM50052119 ((3,3-Dimethyl-butyl)-carbamic acid (3R,4aR,5S,6S,6...) Show SMILES CC(C)(C)CCNC(=O)O[C@@H]1[C@H](O)[C@@]2(C)O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@H]12)C=C Show InChI InChI=1S/C27H45NO7/c1-10-24(7)15-17(30)27(33)25(8)16(29)11-12-23(5,6)19(25)18(20(31)26(27,9)35-24)34-21(32)28-14-13-22(2,3)4/h10,16,18-20,29,31,33H,1,11-15H2,2-9H3,(H,28,32)/t16-,18-,19-,20-,24-,25-,26+,27-/m0/s1	NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	n/a	n/a	2.10E+3	n/a	n/a	n/a	n/a
Food and Drug Administration Curated by ChEMBL					Assay Description Conversion of [32P] ATP to [32P]-cyclic AMP mediated by adenylate cyclase 1				J Med Chem 39: 2745-52 (1996) Article DOI: 10.1021/jm960191+ BindingDB Entry DOI: 10.7270/Q2X34WJG
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 70 total )  |  Next  |  Last  >>

Jump to: